EPO and head and neck squamous cell carcinoma: Our data demonstrating endogenous Epo expression in UMSCC-10B and UMSCC-22B indicates the possible existence of an Epo/EpoR autocrine/paracrine neoplastic pathway which promotes malignant progression of HNSCC, further propagated by administration of exogenous rhEpo.